196 related articles for article (PubMed ID: 12626883)
1. Optimization of ex vivo activation and expansion of macaque primary CD4-enriched peripheral blood mononuclear cells for use in anti-HIV immunotherapy and gene therapy strategies.
Zhang D; Murakami A; Johnson RP; Sui J; Cheng J; Bai J; Marasco WA
J Acquir Immune Defic Syndr; 2003 Mar; 32(3):245-54. PubMed ID: 12626883
[TBL] [Abstract][Full Text] [Related]
2. Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells.
Secchiero P; Zella D; Curreli S; Mirandola P; Capitani S; Gallo RC; Zauli G
J Immunol; 2000 Apr; 164(8):4018-24. PubMed ID: 10754293
[TBL] [Abstract][Full Text] [Related]
3. Optimization of in vitro expansion of macaque CD4 T cells using anti-CD3 and co-stimulation for autotransfusion therapy.
Onlamoon N; Hudson K; Bryan P; Mayne AE; Bonyhadi M; Berenson R; Sundstrom BJ; Bostik P; Ansari AA; Villinger F
J Med Primatol; 2006 Aug; 35(4-5):178-93. PubMed ID: 16872281
[TBL] [Abstract][Full Text] [Related]
4. Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.
Adachi T; Tanaka R; Kodama A; Saito M; Takahashi Y; Ansari AA; Tanaka Y
Retrovirology; 2011 Oct; 8():84. PubMed ID: 22018245
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines.
Juffermans NP; Paxton WA; Dekkers PE; Verbon A; de Jonge E; Speelman P; van Deventer SJ; van der Poll T
Blood; 2000 Oct; 96(8):2649-54. PubMed ID: 11023494
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells.
Carroll RG; Riley JL; Levine BL; Feng Y; Kaushal S; Ritchey DW; Bernstein W; Weislow OS; Brown CR; Berger EA; June CH; St Louis DC
Science; 1997 Apr; 276(5310):273-6. PubMed ID: 9092480
[TBL] [Abstract][Full Text] [Related]
7. A novel role for tumor necrosis factor-alpha in regulating susceptibility of activated CD4+ T cells from human and nonhuman primates for distinct coreceptor using lentiviruses.
Brice GT; Mayne AE; Villinger F; Ansari AA
J Acquir Immune Defic Syndr; 2000 May; 24(1):10-22. PubMed ID: 10877490
[TBL] [Abstract][Full Text] [Related]
8. The mode and duration of anti-CD28 costimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro.
Creson JR; Lin AA; Li Q; Broad DF; Roberts MR; Anderson SJ
J Virol; 1999 Nov; 73(11):9337-47. PubMed ID: 10516042
[TBL] [Abstract][Full Text] [Related]
9. Development of an animal model for autotransfusion therapy: in vitro characterization and analysis of anti-CD3/CD28 expanded cells.
Brice GT; Riley JL; Villinger F; Mayne A; Hillyer CD; June CH; Ansari AA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):210-20. PubMed ID: 9803962
[TBL] [Abstract][Full Text] [Related]
10. High-efficiency gene transfer into rhesus macaque primary T lymphocytes by combining 32 degrees C centrifugation and CH-296-coated plates: effect of gene transfer protocol on T cell homing receptor expression.
Zhou P; Lee J; Moore P; Brasky KM
Hum Gene Ther; 2001 Oct; 12(15):1843-55. PubMed ID: 11589827
[TBL] [Abstract][Full Text] [Related]
11. A closed-culture system using a GMP-grade culture bag and anti-CD3/28 coated bead stimulation for CD4
Thitilertdecha P; Suwannachod P; Poungpairoj P; Tantithavorn V; Khowawisetsut L; Ammaranond P; Onlamoon N
J Immunol Methods; 2018 Sep; 460():17-25. PubMed ID: 29894747
[TBL] [Abstract][Full Text] [Related]
12. Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5.
Maier DA; Brennan AL; Jiang S; Binder-Scholl GK; Lee G; Plesa G; Zheng Z; Cotte J; Carpenito C; Wood T; Spratt SK; Ando D; Gregory P; Holmes MC; Perez EE; Riley JL; Carroll RG; June CH; Levine BL
Hum Gene Ther; 2013 Mar; 24(3):245-58. PubMed ID: 23360514
[TBL] [Abstract][Full Text] [Related]
13. A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes.
Thomas AK; Maus MV; Shalaby WS; June CH; Riley JL
Clin Immunol; 2002 Dec; 105(3):259-72. PubMed ID: 12498807
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of tumor reactive CD4+ cells generated from tumor-primed lymph nodes using anti-CD3/anti-CD28 monoclonal antibodies.
Li Q; Yu B; Grover AC; Zeng X; Chang AE
J Immunother; 2002; 25(4):304-13. PubMed ID: 12142553
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
16. Determination of cell expansion and surface molecule expression on anti-CD3/28 expanded CD4
Thitilertdecha P; Poungpairoj P; Tantithavorn V; Ammaranond P; Onlamoon N
Scand J Immunol; 2019 Nov; 90(5):e12808. PubMed ID: 31322752
[TBL] [Abstract][Full Text] [Related]
17. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
[TBL] [Abstract][Full Text] [Related]
18. In vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat.
Braun SE; Taube R; Zhu Q; Wong FE; Murakami A; Kamau E; Dwyer M; Qiu G; Daigle J; Carville A; Johnson RP; Marasco WA
Hum Gene Ther; 2012 Sep; 23(9):917-31. PubMed ID: 22734618
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation.
Levine BL; Mosca JD; Riley JL; Carroll RG; Vahey MT; Jagodzinski LL; Wagner KF; Mayers DL; Burke DS; Weislow OS; St Louis DC; June CH
Science; 1996 Jun; 272(5270):1939-43. PubMed ID: 8658167
[TBL] [Abstract][Full Text] [Related]
20. Low T-cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS.
Roos MT; Prins M; Koot M; de Wolf F; Bakker M; Coutinho RA; Miedema F; Schellekens PT
AIDS; 1998 Oct; 12(14):1745-51. PubMed ID: 9792374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
